It is our pleasure to invite you to The Inaugural West Coast ‘Advancing Drug Development Forum - Making the Impossible, Possible’ scheduled to take place June 14, 2018 at the San Francisco Wine School in South San Francisco, CA from 8:30 AM – 8:30 PM.
Like ‘The Inaugural Advancing Drug Development Forum - Making the Impossible, Possible' event that took place in December 2017 in Boston, this inaugural West Coast forum program aims to bring together key opinion leaders in biotech and pharma, executive leadership, senior directors, consultants, and a close network of non-competitive CROs and CDMOs to explore together novel solutions, promising technology breakthroughs and how industry introduces and incorporates improved approaches in small molecule drug development.
The program will include two keynote presentations, several provocative and focused panel discussions and plenty of opportunity for inactive dialogue between faculty and attendees. Everyone is invited to explore and share various approaches so that together we can find better ways to break down barriers and improve the process for developing complex drug formulation and manufacturing methods.
Within this scope, we will explore how biotech and pharma executives, consultants, CROs and CDMOs must work seamlessly together and how critical it is to invest their resources to meet the demands and expectations to develop high quality drug products. We will also explore what challenges still lie ahead and how we must find better solutions to develop complex compounds in order to treat unmet medical needs.
The event is specially designed to bring a focused group together to exchange ideas and experiences. Plenty of time has been woven throughout the day to assure interactive dialogue and quality networking opportunities for all.
June 14, 2018
8:30 AM - 8:30 PM
San Francisco Wine School
415 Grand Avenue, Suite 301
South San Francisco, CA 94080
Senior scientists, through vice presidents in small molecule formulation development, CMC, drug product, drug substance and API manufacturing with expertise and focus on implementation of (new) technologies that accelerate development and improve quality and the regulatory process- product life cycle associated with new technologies.
"It was great to learn how important an openness is when it comes to data collection and consolidation. Secondly, so much of our client's clinical studies success relied on having strong expertise in the CMC and Manufacturing areas. Before a pill/biologic or even cell therapy can even enter a mouse it has to be designed properly. If more companies focused on this area early and more often, I feel the likelihood of success would dramatically increase."
Paul Fabre, Bioservices
"Appreciated the refreshing and openly honest dialogue between all forum participants. The attendees experiences enhanced our tool box to deal with challenges in the business and the event led to a broader appreciation of the common trials and tribulations experienced by many."
Simon McGurk, Executive Director at TESARO, Inc.
“The Advancing Drug Development Forum was great. High-yield learning on the latest issues in drug development and quality with excellent speakers that represented many facets of development, from C-suite to scientific. Highly recommended!”
Nate Pinches, Eagle Hill Consulting
Copyright © 2018 Advancing Drug Development Forum | All Rights Reserved.